Cargando…
Acute Promyelocytic Leukemia and Severe Differentiation Syndrome in Pregnancy—A Management Challenge
Acute promyelocytic leukemia (APL) is generated by the PML-RARA fusion gene. In patients suffering from APL, the early diagnosis and treatment are essential in the successful management. We reported a case of a 27-year-old 17th-week pregnant patient diagnosed with APL. After an extensive hematologic...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221439/ https://www.ncbi.nlm.nih.gov/pubmed/37240786 http://dx.doi.org/10.3390/life13051141 |
_version_ | 1785049456518889472 |
---|---|
author | Droc, Gabriela Stancioaica, Maria Camelia Soare, Corina Gabriela Stefan, Mihai-Gabriel Ingustu, Daiana Martac, Cristina Coriu, Daniel Isac, Sebastian Suciu, Nicolae Andrei, Stefan |
author_facet | Droc, Gabriela Stancioaica, Maria Camelia Soare, Corina Gabriela Stefan, Mihai-Gabriel Ingustu, Daiana Martac, Cristina Coriu, Daniel Isac, Sebastian Suciu, Nicolae Andrei, Stefan |
author_sort | Droc, Gabriela |
collection | PubMed |
description | Acute promyelocytic leukemia (APL) is generated by the PML-RARA fusion gene. In patients suffering from APL, the early diagnosis and treatment are essential in the successful management. We reported a case of a 27-year-old 17th-week pregnant patient diagnosed with APL. After an extensive hematological diagnostic panel, the acute promyelocytic leukemia was confirmed, and the patient received all-trans retinoic acid (ATRA), idarubicin (IDA), and dexamethasone, following national guidelines. Due to ATRA-related differentiation syndrome, the therapy was adjusted, and hydroxycarbamide was added with a good outcome. The patient was admitted to the ICU secondary to hypoxemic respiratory failure on the 2nd day after hospital admission. Our patient received an individualized drug combination, adjusted by the clinical response. Furthermore, the drugs used in APL treatment are all teratogenic. Despite various major complications, including severe acute respiratory distress syndrome (ARDS), which needed mechanical ventilation; ICU-acquired myopathy; and spontaneous abortion, the patient had a good outcome and was transferred from the ICU after a total stay of 40 days. APL during pregnancy is a rare entity of intermediate-risk APL. Our study emphasized the need for individualized therapy in a rare case of a pregnant woman diagnosed with a potentially fatal hematologic disease. |
format | Online Article Text |
id | pubmed-10221439 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102214392023-05-28 Acute Promyelocytic Leukemia and Severe Differentiation Syndrome in Pregnancy—A Management Challenge Droc, Gabriela Stancioaica, Maria Camelia Soare, Corina Gabriela Stefan, Mihai-Gabriel Ingustu, Daiana Martac, Cristina Coriu, Daniel Isac, Sebastian Suciu, Nicolae Andrei, Stefan Life (Basel) Case Report Acute promyelocytic leukemia (APL) is generated by the PML-RARA fusion gene. In patients suffering from APL, the early diagnosis and treatment are essential in the successful management. We reported a case of a 27-year-old 17th-week pregnant patient diagnosed with APL. After an extensive hematological diagnostic panel, the acute promyelocytic leukemia was confirmed, and the patient received all-trans retinoic acid (ATRA), idarubicin (IDA), and dexamethasone, following national guidelines. Due to ATRA-related differentiation syndrome, the therapy was adjusted, and hydroxycarbamide was added with a good outcome. The patient was admitted to the ICU secondary to hypoxemic respiratory failure on the 2nd day after hospital admission. Our patient received an individualized drug combination, adjusted by the clinical response. Furthermore, the drugs used in APL treatment are all teratogenic. Despite various major complications, including severe acute respiratory distress syndrome (ARDS), which needed mechanical ventilation; ICU-acquired myopathy; and spontaneous abortion, the patient had a good outcome and was transferred from the ICU after a total stay of 40 days. APL during pregnancy is a rare entity of intermediate-risk APL. Our study emphasized the need for individualized therapy in a rare case of a pregnant woman diagnosed with a potentially fatal hematologic disease. MDPI 2023-05-08 /pmc/articles/PMC10221439/ /pubmed/37240786 http://dx.doi.org/10.3390/life13051141 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Case Report Droc, Gabriela Stancioaica, Maria Camelia Soare, Corina Gabriela Stefan, Mihai-Gabriel Ingustu, Daiana Martac, Cristina Coriu, Daniel Isac, Sebastian Suciu, Nicolae Andrei, Stefan Acute Promyelocytic Leukemia and Severe Differentiation Syndrome in Pregnancy—A Management Challenge |
title | Acute Promyelocytic Leukemia and Severe Differentiation Syndrome in Pregnancy—A Management Challenge |
title_full | Acute Promyelocytic Leukemia and Severe Differentiation Syndrome in Pregnancy—A Management Challenge |
title_fullStr | Acute Promyelocytic Leukemia and Severe Differentiation Syndrome in Pregnancy—A Management Challenge |
title_full_unstemmed | Acute Promyelocytic Leukemia and Severe Differentiation Syndrome in Pregnancy—A Management Challenge |
title_short | Acute Promyelocytic Leukemia and Severe Differentiation Syndrome in Pregnancy—A Management Challenge |
title_sort | acute promyelocytic leukemia and severe differentiation syndrome in pregnancy—a management challenge |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221439/ https://www.ncbi.nlm.nih.gov/pubmed/37240786 http://dx.doi.org/10.3390/life13051141 |
work_keys_str_mv | AT drocgabriela acutepromyelocyticleukemiaandseveredifferentiationsyndromeinpregnancyamanagementchallenge AT stancioaicamariacamelia acutepromyelocyticleukemiaandseveredifferentiationsyndromeinpregnancyamanagementchallenge AT soarecorinagabriela acutepromyelocyticleukemiaandseveredifferentiationsyndromeinpregnancyamanagementchallenge AT stefanmihaigabriel acutepromyelocyticleukemiaandseveredifferentiationsyndromeinpregnancyamanagementchallenge AT ingustudaiana acutepromyelocyticleukemiaandseveredifferentiationsyndromeinpregnancyamanagementchallenge AT martaccristina acutepromyelocyticleukemiaandseveredifferentiationsyndromeinpregnancyamanagementchallenge AT coriudaniel acutepromyelocyticleukemiaandseveredifferentiationsyndromeinpregnancyamanagementchallenge AT isacsebastian acutepromyelocyticleukemiaandseveredifferentiationsyndromeinpregnancyamanagementchallenge AT suciunicolae acutepromyelocyticleukemiaandseveredifferentiationsyndromeinpregnancyamanagementchallenge AT andreistefan acutepromyelocyticleukemiaandseveredifferentiationsyndromeinpregnancyamanagementchallenge |